Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
AIXTRON SE (NASDAQ: AIXG) shares declined 3.83 percent to close at $16.31 a share Tuesday. The stock traded between $16.15 and $16.50 on volume of 383,876 shares traded. Analysts at Canaccord have recently downgraded the company’s rating to "sell" from "hold". Shares of AIXTRON have gained approximately 36.0 percent year-to-date.
Find out more about AIXTRON including full access to the free equity report at:
Family Dollar Stores, Inc. (NYSE: FDO) shares increased 0.54 percent to close at $72.41 a share Tuesday. The stock traded between $71.47 and $72.67 on volume of 1.59 million shares traded. Analysts at Northcoast have recently downgraded the company’s rating to "neutral" from "buy". Shares of Family Dollar Stores have gained approximately 14.0 percent year-to-date.
Find out more about Family Dollar Stores including full access to the free equity report at:
MedAssets, Inc. (NASDAQ: MDAS) shares declined 2.16 percent to close at $24.87 a share Tuesday. The stock traded between $24.45 and $25.27 on volume of 873,731 shares traded. Analysts at Raymond James have recently downgraded the company’s rating to "market perform" from "strong buy". Shares of MedAssets have gained approximately 48.0 percent year-to-date.
Find out more about MedAssets including full access to the free equity report at:
Rentech Nitrogen Partners LP (NYSE: RNF) shares increased 4.16 percent to close at $25.54 a share Tuesday. The stock traded between $24.41 and $25.54 on volume of 89,583 shares traded. Analysts at Credit Suisse have recently initiated coverage on the company with a "neutral" rating and a price target of $27.00. Shares of Rentech Nitrogen Partners have fallen approximately 32.0 percent year-to-date.
Find out more about Rentech Nitrogen Partners including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing
Leave a comment...